JOHNSTOWN, Pa., Feb. 25, 2016 -- Concurrent Technologies Corporation's fiscal year 2015 annual report has won a gold MarCom Award, marking the tenth consecutive year that the publication has been honored in a national or international competition.
"These competitions measure us against fortune 500 companies and media conglomerates as well as companies closer to our size, and we are honored to be judged as exceptional alongside the best in the industry," says Mary Bevan, Director, Corporate Communications and Brand Marketing, Concurrent Technologies Corporation.
"This year's Gold MarCom Award is especially gratifying because it is the tenth consecutive year that our company's annual report has won a major honor. I want to recognize our writer, Beth Ann Lombardi, and our graphic designer, Carianne Weakland, who have consistently brought their top game to this publication. Their talent and dedication to excellence have made it possible for the annual report to win a total of 15 awards over the past ten years including APEX, Hermes, MarCom and Service Industry Advertising Awards."
Bevan serves as the project manager for the annual report. She noted that the publication has earned nine gold awards and one platinum award over the past decade. Other team members who contributed to this year's annual report are David Covolo, Michael Hull, Molly McQuillan, Sharon Paterson, Stephanie Putt, Ed Sheehan, and Tricia Wright.
MarCom Awards is administered and judged by the Association of Marketing and Communication Professionals. Judges for the international organization are industry professionals who look for companies and individuals whose talents exceed a high standard of excellence and whose work serves as a benchmark for the industry. The competition received about 6,500 entries from throughout the United States, Canada and more than a dozen other countries.
Concurrent Technologies Corporation (CTC) is an independent, nonprofit, applied scientific research and development professional services organization. Together with our affiliates, Enterprise Ventures Corporation and CTC Foundation, we leverage research, development, test and evaluation work to provide transformative, full lifecycle solutions. To best serve our clients' needs, we offer the complete ability to fully design, develop, test, prototype, and build. We support our clients' core mission objectives with customized solutions and strive to exceed expectations. CTC has been named one of the World's Most Ethical Companies by Ethisphere Institute, the global leader in defining and advancing the standards of ethical business practices. In addition, CTC has been named a Best for Vets Employer by Military Times. For more information about CTC, visit www.ctc.com.
CONTACT: Media Contact: Mary Bevan
814-269-2490 or [email protected]


Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



